中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
Chinese Journal of Experimental Surgery
2015年
9期
2276-2278
,共3页
方泽民%陈军%胡敏%刘立刚%郑萍%魏翔
方澤民%陳軍%鬍敏%劉立剛%鄭萍%魏翔
방택민%진군%호민%류립강%정평%위상
肺动脉高压%心脏移植%并发症%存活率
肺動脈高壓%心髒移植%併髮癥%存活率
폐동맥고압%심장이식%병발증%존활솔
Pulmonary hypertension%Heart transplantation%Complications%Survival
目的 观察心脏移植患者术前肺动脉高压对术后早期并发症及存活的影响.方法 分析76例心脏移植患者住院资料.根据术前肺动脉收缩压(sPAP)是否≥45 mmHg(1 mmHg=0 133 kPa)分为肺动脉高压组(n=22)和对照组(n=54).分析比较两组受者术前一般资料、术后并发症发生率及术后早期存活率.结果 肺动脉高压组与对照组受者术前sPAP分别为(52.0±4.6) mmHg和(28.0±5.2) mmHg,两组患者术前的吸烟史百分率、原发病中心肌病百分率、氨基末端B型利钠肽前体(NT-proBNP)、中心静脉压(CVP)和移植前心力衰竭时间的差异有统计学意义(P<0.05).两组术后机械通气时间、右心衰竭发生率、二次插管/气管切开率、需持续肾脏替代治疗(CRRT)或体外膜肺氧合(ECMO)支持治疗应用率以及ICU住院时间的差异也有统计学意义(P<0.05).两组术后早期存活率分别为95.5%和96.3%,差异无统计学意义(P>0.05).结论 术前肺动脉高压的心脏移植患者术后并发症发生率高于对照组,经有效降低肺动脉高压治疗后术后早期存活率未受影响.
目的 觀察心髒移植患者術前肺動脈高壓對術後早期併髮癥及存活的影響.方法 分析76例心髒移植患者住院資料.根據術前肺動脈收縮壓(sPAP)是否≥45 mmHg(1 mmHg=0 133 kPa)分為肺動脈高壓組(n=22)和對照組(n=54).分析比較兩組受者術前一般資料、術後併髮癥髮生率及術後早期存活率.結果 肺動脈高壓組與對照組受者術前sPAP分彆為(52.0±4.6) mmHg和(28.0±5.2) mmHg,兩組患者術前的吸煙史百分率、原髮病中心肌病百分率、氨基末耑B型利鈉肽前體(NT-proBNP)、中心靜脈壓(CVP)和移植前心力衰竭時間的差異有統計學意義(P<0.05).兩組術後機械通氣時間、右心衰竭髮生率、二次插管/氣管切開率、需持續腎髒替代治療(CRRT)或體外膜肺氧閤(ECMO)支持治療應用率以及ICU住院時間的差異也有統計學意義(P<0.05).兩組術後早期存活率分彆為95.5%和96.3%,差異無統計學意義(P>0.05).結論 術前肺動脈高壓的心髒移植患者術後併髮癥髮生率高于對照組,經有效降低肺動脈高壓治療後術後早期存活率未受影響.
목적 관찰심장이식환자술전폐동맥고압대술후조기병발증급존활적영향.방법 분석76례심장이식환자주원자료.근거술전폐동맥수축압(sPAP)시부≥45 mmHg(1 mmHg=0 133 kPa)분위폐동맥고압조(n=22)화대조조(n=54).분석비교량조수자술전일반자료、술후병발증발생솔급술후조기존활솔.결과 폐동맥고압조여대조조수자술전sPAP분별위(52.0±4.6) mmHg화(28.0±5.2) mmHg,량조환자술전적흡연사백분솔、원발병중심기병백분솔、안기말단B형리납태전체(NT-proBNP)、중심정맥압(CVP)화이식전심력쇠갈시간적차이유통계학의의(P<0.05).량조술후궤계통기시간、우심쇠갈발생솔、이차삽관/기관절개솔、수지속신장체대치료(CRRT)혹체외막폐양합(ECMO)지지치료응용솔이급ICU주원시간적차이야유통계학의의(P<0.05).량조술후조기존활솔분별위95.5%화96.3%,차이무통계학의의(P>0.05).결론 술전폐동맥고압적심장이식환자술후병발증발생솔고우대조조,경유효강저폐동맥고압치료후술후조기존활솔미수영향.
Objective To determine the influence of preoperative pulmonary hypertension on the early complications and survival after heart transplantation.Methods Seventy-six patients receiving heart transplantation were divided into two groups according to preoperative pulmonary arterial systolic pressure (sPAP):pulmonary hypertension group (n=22),preoperative sPAP ≥ 45 mmHg (i mmHg=0.133 kPa);control group (n =54),preoperative sPAP <45 mmHg.Clinical characteristic data,postoperative recovery data and early survival of two groups were compared.Results sPAP in pulmonary hypertension group was significantly higher than that in control group [(52.0 ± 4.6) mmHg vs.(28.0 ± 5.2 mmHg),P < 0.05].Preoperative N-terminal pro-brain natriuretic peptide (NT-proBNP),central venous pressure (CVP),length of heart failure,incidence of smoking and cardiomyopathy in pulmonary hypertension group were significantly higher than those in control group (P < 0.05).Postoperative duration of mechanical ventilation,ICU length of stay,incidence of right heart failure,tracheotomy and complications required continuous renal replacement therapy (CRRT)/extracorporeal membrane oxygenation (ECMO) support had statistically significant difference between two groups (P < 0.05).There was no statistically significant difference in the early postoperative survival between two groups (P > 0.05).Conclusion The early postoperative complications were related to preoperative pulmonary hypertension in heart transplant patients.The early postoperative survival was not affected by effectively controlling pulmonary hypertension.